These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


53 related items for PubMed ID: 8519689

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mitogenesis by v-Src: fluctuations throughout G1 of classical immediate early AP-1 and mitogen-activated protein kinase responses that parallel the need for the oncoprotein.
    Wyke AW, Frame MC, Gillespie DA, Chudleigh A, Wyke JA.
    Cell Growth Differ; 1995 Oct; 6(10):1225-34. PubMed ID: 8845299
    [Abstract] [Full Text] [Related]

  • 4. Adhesion-dependency of serum-induced p42/p44 MAP kinase activation is released by retroviral oncogenes.
    Inoue H, Yamashita A, Hakura A.
    Virology; 1996 Nov 01; 225(1):223-6. PubMed ID: 8918550
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F, Bonnec G, Tardivel A, Boujard D.
    Dev Biol; 1997 Aug 01; 188(1):122-33. PubMed ID: 9245517
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN, Abramova MV, Svetlikova SB, Darieva ZA, Pospelova TV, Pospelov VA.
    Oncogene; 2002 Jan 24; 21(5):719-30. PubMed ID: 11850800
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Similarities between somatic cells overexpressing the mos oncogene and oocytes during meiotic interphase.
    Fukasawa K, Murakami MS, Blair DG, Kuriyama R, Hunt T, Fischinger P, Vande Woude GF.
    Cell Growth Differ; 1994 Oct 24; 5(10):1093-103. PubMed ID: 7848911
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor.
    York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW, Stork PJ.
    Nature; 1998 Apr 09; 392(6676):622-6. PubMed ID: 9560161
    [Abstract] [Full Text] [Related]

  • 13. Mos proto-oncogene function during oocyte maturation in Xenopus.
    Roy LM, Haccard O, Izumi T, Lattes BG, Lewellyn AL, Maller JL.
    Oncogene; 1996 May 16; 12(10):2203-11. PubMed ID: 8668347
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
    Franklin CC, Kraft AS.
    Oncogene; 1995 Dec 07; 11(11):2365-74. PubMed ID: 8570188
    [Abstract] [Full Text] [Related]

  • 16. An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression.
    Le Gall M, Grall D, Chambard JC, Pouysségur J, Van Obberghen-Schilling E.
    Oncogene; 1998 Sep 10; 17(10):1271-7. PubMed ID: 9771970
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ser-3 is important for regulating Mos interaction with and stimulation of mitogen-activated protein kinase kinase.
    Chen M, Cooper JA.
    Mol Cell Biol; 1995 Sep 10; 15(9):4727-34. PubMed ID: 7651390
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.